Overview

ATV/Ritonavir Nevirapine Interaction (USPAC)

Status:
Completed

Trial end date:
2006-07-01

Target enrollment:

Participant gender:

Summary

Open-Label, multiple-dose, drug interaction study to assess the effect of nevirapine on the pharmacokinetics of atazanavir in HIV-infected individuals.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Atazanavir Sulfate
Nevirapine
Ritonavir